Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Surge Therapeutics

Clinical trials sponsored by Surge Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug STM-416p tested during prostate surgery in small safety trial Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 1 Completed 1

Can a One-Time Anti-Inflammatory shot during surgery curb Triple-Negative breast Cancer's return?

Disease control Not yet recruiting

This phase 3 trial tests whether a single dose of SRG-514 (ketorolac), given directly into the area where a breast tumor is removed, can help prevent cancer from coming back. The study enrolls adults with stage II-III triple-negative breast cancer who are having breast-conserving…

Phase 3 • Sponsor: SURGE Therapeutics • Aim: Disease control

Last updated Jul 25, 2026 00:00 UTC